Pharma Journalist -

Aeterna Zentaris Inc. a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, announced it has expanded…
Read More...

Intellia Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Intellia’s ex vivo investigational T cell receptor (TCR)-T…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Kriya Therapeutics, Inc., a…
Read More...

BriOri BioTech, an emerging pre-clinical stage biotech company focused on developing a pipeline of opiate-free topical pain medications, announces its patent for “Topical Compositions…
Read More...

The MIKADO group, a translational team at the UZH focused on generating evidence-driven insights to understand and treat rare inherited kidney diseases, and Insilico Medicine, an…
Read More...

Pfizer Inc. announced that it has initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease Inhibition for COVID-19 in Pediatric Patients), to evaluate the safety,…
Read More...

Cellevolve Bio a development and commercialization company focused on cell therapies and Seattle Children’s Therapeutics, a venture at Seattle Children's, bringing cutting edge,…
Read More...

SMi Group reports: Key pressing questions on rapid microbial methods, contamination control, sterility assurance and environmental monitoring will be addressed at the Microbiology East…
Read More...

Aldeyra Therapeutics, Inc. announced that it has initiated a Phase 2 clinical trial of ADX-2191 (intravitreal methotrexate 0.8%), an investigational new drug product, for the treatment…
Read More...

ABEC announced it will provide customized, large-scale bioprocess equipment, including a 14,500 liter total volume stainless steel fermenter and an 8,000 liter media preparation system…
Read More...